Giulia Bon

8PUBLICATIONS
38CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.

|Mar 26, 2026
Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer.

Giulia Schiavoni, Antonella Palmese, Stefano Scalera

|Jul 09, 2024
Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy.

Stefano Scalera, Biagio Ricciuti, Daniele Marinelli

|Feb 29, 2024
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.

Giulia Schiavoni, Beatrice Messina, Stefano Scalera

|Jan 12, 2023
Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression.

Beatrice Messina, Federica Lo Sardo, Stefano Scalera

|Apr 20, 2022
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.

Rossella Loria, Valentina Laquintana, Stefano Scalera

Pageof 2

Frequent Collaborators

3 joint publications

Stefano Scalera

2 joint publications

Maurizio Fanciulli

2 joint publications

Giovanni Blandino

2 joint publications

Gennaro Ciliberto